{
    "2021-04-05": [
        [
            {
                "time": "",
                "orginal_text": "26亿美安进连并两家biotech，背后逻辑是什么？又与中国药企有怎样的联系？",
                "features": {
                    "keywords": [
                        "安进",
                        "biotech",
                        "并购",
                        "中国药企"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "海外策略｜海外“全中国组合” — 2021年4月",
                "features": {
                    "keywords": [
                        "海外策略",
                        "全中国组合",
                        "2021年4月"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "中信证券：3月A股、港股延续节后调整 没看到资金流出新兴市场",
                "features": {
                    "keywords": [
                        "中信证券",
                        "A股",
                        "港股",
                        "调整",
                        "资金流出",
                        "新兴市场"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业一周观察：调整后重归均衡 关注内生成长明确的一二线公司",
                "features": {
                    "keywords": [
                        "医药行业",
                        "调整",
                        "均衡",
                        "内生成长",
                        "一二线公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "一文看懂为何近期医疗服务、医美标的股价反弹涨幅较大",
                "features": {
                    "keywords": [
                        "医疗服务",
                        "医美",
                        "股价反弹",
                        "涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业2021年4月投资策略：业绩驱动渐入佳境",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2021年4月",
                        "投资策略",
                        "业绩驱动"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}